Bioavailability and Bioequivalence
- ICH M9: Guideline on Biopharmaceutics Classification System - based Biowaiver
- Guidance Document: Conduct and Analysis of Comparative Bioavailability Studies [2018-06-08]
- Guidance Document: Comparative Bioavailability Standards: Formulations used for Systemic Effects [2018-06-08]
- Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Market Entry Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis [2011-09-19]
- Draft Guidance for Industry: Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format [2004-05-12]
Page details
- Date modified: